This topic contains a solution. Click here to go to the answer

Author Question: If the price level in an economy increases, other things constant, consumption spending is likely to ... (Read 50 times)

rachel9

  • Sr. Member
  • ****
  • Posts: 495
If the price level in an economy increases, other things constant, consumption spending is likely to _____.
 a. increase because real income increases
 b. decrease because real income increases
 c. increase because the real value of wealth increases
  d. decrease because the real value of wealth decreases
  e. increase because nominal income increases

Question 2

In the United States, paper money is redeemable for gold.
 a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wtf444

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

d

Answer to Question 2

False




rachel9

  • Member
  • Posts: 495
Reply 2 on: Jun 30, 2018
:D TYSM


abro1885

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library